Evidence map›Paper›PMID 40055185›Full record

ArticleCellular and molecular life sciences : CMLS2025

IGF2BP1-HAX-1 positive feedback loop-mediated HAX-1 overexpression blocks autophagic flux and promotes chemoresistance in nasopharyngeal carcinoma.

Siyu Zhang, Miao Gu, Haimeng Yin, Si Pan, Haijing Xie, Wenhui Chen, Sheraz Gul, Yue Zhao, Zhefang Wang, Wenjie Zheng and 2 more

Abstract read
In one paragraph

Article in Cellular and molecular life sciences : CMLS, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Siyu ZhangDepartment of Otorhinolaryngology Head and Neck Surgery, Affiliated Hospital of Nantong University, Xisi Road 20, Nantong, 226019, Jiangsu Province, China.
Miao GuDepartment of Otorhinolaryngology Head and Neck Surgery, Affiliated Hospital of Nantong University, Xisi Road 20, Nantong, 226019, Jiangsu Province, China.
Haimeng YinDepartment of Otorhinolaryngology Head and Neck Surgery, Affiliated Hospital of Nantong University, Xisi Road 20, Nantong, 226019, Jiangsu Province, China.
Si PanDepartment of Otorhinolaryngology Head and Neck Surgery, Affiliated Hospital of Nantong University, Xisi Road 20, Nantong, 226019, Jiangsu Province, China.
Haijing XieDepartment of Otorhinolaryngology Head and Neck Surgery, Affiliated Hospital of Nantong University, Xisi Road 20, Nantong, 226019, Jiangsu Province, China.
Wenhui ChenDepartment of Otorhinolaryngology Head and Neck Surgery, Affiliated Hospital of Nantong University, Xisi Road 20, Nantong, 226019, Jiangsu Province, China.
Sheraz GulFraunhofer Institute for Translational Medicine and Pharmacology (ITMP), Hamburg, Germany.
Yue ZhaoDepartment of General, Visceral and Cancer Surgery, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.
Zhefang WangDepartment of Plastic and Reconstructive Surgery, Second Affiliated Hospital of Zhejiang University School of Medicine, Jiefang Road 88, Hangzhou, Zhejiang, P. R. China.
Wenjie ZhengResearch Center of Clinical Medicine, Nantong University Medical School, Affiliated Hospital of Nantong University, Nantong, 226019, Jiangsu Province, China. wenjiezheng@ntu.edu.cn.
Yiwen YouDepartment of Otorhinolaryngology Head and Neck Surgery, Affiliated Hospital of Nantong University, Xisi Road 20, Nantong, 226019, Jiangsu Province, China. youyiwen_ent@163.com.
Bo YouDepartment of Otorhinolaryngology Head and Neck Surgery, Affiliated Hospital of Nantong University, Xisi Road 20, Nantong, 226019, Jiangsu Province, China. youbo@ntu.edu.cn.ORCID http://orcid.org/0000-0002-3602-5264

Funding

National Natural Science Foundation of China 81972554National Natural Science Foundation of China 82102701National Natural Science Foundation of China 82173288National Natural Science Foundation of China 82272839National Natural Science Foundation of China 82372977Natural Science Foundation of Jiangsu Province BK20201208Outstanding Youth Foundation of Jiangsu Province BK20240127
6 · The paper itself

Abstract

Autophagy is associated with chemoresistance, which is the leading cause of failure in chemotherapeutic treatments. Among the various aspects of autophagy, autophagic flux serves as a critical indicator for evaluating the dynamic processes involved.We report herein that the multifunctional protein HAX-1 promotes chemoresistance by effectively blocking the fusion of autophagosomes with lysosomes. Complementary mass spectrometric and functional studies also demonstrated that HAX-1 recruits NEDD4 to promote Rab7a degradation and inhibits binding of Rab7a with SNAREs by competitively binding to it. Furthermore, HAX-1 binds IGF2BP1 mRNA, thereby contributing to its stability and translation. Moreover, IGF2BP1 enhanced HAX-1 m6A methylation, thereby enhancing its stability. By way of in-vivo and in-vitro experiments, we confirmed the positive role of the IGF2BP1-HAX-1 feedback loop in chemoresistance. Taken together, our findings provide evidence that monitoring of HAX-1, IGF2BP1, and SQSTM1 levels can serve as useful predictors of clinical outcome and chemoresistance risk. In addition, our data provide new insights into the clinical applications of therapies related to autophagic flux and its associated molecular network in targeting cisplatin chemoresistance in nasopharyngeal carcinoma.

Indexed as

AutophagyDrug Resistance, NeoplasmNasopharyngeal CarcinomaNasopharyngeal NeoplasmsRNA-Binding ProteinsAnimalsCell Line, TumorCisplatinFeedback, PhysiologicalGene Expression Regulation, NeoplasticHEK293 CellsHumansLysosomesMiceMice, Inbred BALB CMice, NudeCisplatinIGF2BP1 protein, humanNedd4 Ubiquitin Protein Ligasesrab7 GTP-Binding Proteinsrab7 GTP-binding proteins, humanrab GTP-Binding ProteinsRNA-Binding ProteinsSequestosome-1 ProteinSQSTM1 protein, humanAutophagic fluxCarcinomaChemoresistanceHAX-1IGF2BP1NasopharyngealRab7a

Identifiers

PMID40055185
PMCPMC11889316

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.